FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula 1, where X represents a C1-C4 alkylsulfonyl group, Y2 and Y3 each independently represents a C1-C4 alkyl group, unsubstituted or substituted with deuterium, and Y1 represents a methyl group substituted by one or more atoms of deuterium, or a pharmaceutically acceptable salt thereof. A pharmaceutical composition for the treatment of lung cancer, including the specified compound, is also proposed.
EFFECT: compound represented by Formula 1 effectively inhibits the growth of ALK-mutated and EGFR-mutated cancer cells.
7 cl, 4 dwg, 1 tbl, 8 ex
| Title |
Year |
Author |
Number |
| NOVEL HETEROCYCLIC SUBSTITUTED PYRIMIDINE DERIVATIVE EXHIBITING INHIBITORY ACTION ON CANCER CELL GROWTH, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
2020 |
- Kim, Sung-Eun
- Lee, Sunho
- Rajesh, Rengasamy
- Lee, Yong Hyub
- Hong, Sung Tak
|
RU2834201C1 |
| NEW PYRIMIDINE DERIVATIVE WITH AN EFFECT OF INHIBITING GROWTH OF CANCER CELLS AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
2018 |
- Kim, Sung-Eun
- Lee, Sunho
- Rajesh, Rengasamy
- Kang, Dae Ho
- Ryu, Hyung Chul
- Kim, Jae-Sun
- Lee, Sangryul
- Kim, Kyong Cheol
- Rho, Jin Kyung
- Lee, Jae Cheol
|
RU2744168C1 |
| PYRIMIDINE DERIVATIVE WITH INHIBITORY ACTIVITY ON PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION CONTAINING SAME |
2022 |
- Sim, Tae Bo
- Cho, Byoung Chul
- Cho, Han Na
- Sengupta, Sandip
- Malla Reddy, Gannarapu
- Kim, Young Hoon
|
RU2833427C2 |
| NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER |
2022 |
- Lee, Kwangho
- Duggirala, Krishna Babu
- Choi, Gildon
- Lee, Yujin
- Chae, Chong Hak
- Jung, Myoung Eun
- Cho, Byoung Chul
|
RU2831452C2 |
| PYRIMIDINE DERIVATIVE THAT SUPPRESSES CANCER CELL GROWTH AND MEDICAL APPLICATION THEREOF |
2020 |
- Ryu, Hyung-Chul
- Kim, Jae-Sun
- Kim, Sung-Eun
- Lee, Sun-Ho
- Lee, Yong-Hyub
|
RU2792849C1 |
| PYRROLO-PYRIDINE COMPOUND DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING PROTEIN KINASE RELATED DISEASES |
2018 |
- Choi, Hwan Geun
- Ko, Eunhwa
- Cho, Joong-Heui
- Son, Jung Beom
- Ko, Yi Kyung
- Park, Jin-Hee
- Kim, So Young
- Kang, Seock Yong
- Lee, Seungyeon
- Ryu, Hee Yoon
- Kim, Nam Doo
- Kim, Sang Bum
- Lee, Sun-Hwa
- Kim, Dayea
- Lee, Sun Joo
- Cho, Sungchan
- Lee, Kyu-Sun
- Yu, Kweon
- Choi, Miri
- Koo, Ja Wook
- Hoe, Hyang-Sook
|
RU2730849C1 |
| DYETERED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH CONNECTIONS |
2014 |
- Lv Binkhua
- Li Chenvej
- Tsao Benven
- Pan Syujdun
|
RU2632907C2 |
| COMPOUNDS FOR INHIBITING KINASE EGFR, METHODS FOR PRODUCTION AND USE THEREOF |
2020 |
- Xie, Yuli
- Cao, Gang
- Fan, Houxing
|
RU2832925C2 |
| SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2607371C1 |
| PROTEIN TYROSINE KINASE MODULATORS AND METHODS OF USE |
2014 |
- Hu, Shaojing
- Liu, Xiangyong
- Bai, Jinlong
- Long, Wei
|
RU2656591C2 |
